Answers are grounded in this paper and cite their sources.
Three new trinuclear complexes based on [Cu(Ln)]2+ (L1 = 1,5,8,12-tetramethyl-1,3,6,8,10,13-hexaazacyclotetradecane, L2 = 1,3-propanediamine (tn)) and [M(bpb)(CN)2]− (bpb2− = 1,2-bis(pyridine-2-carboxamido)benzenate, M = Fe or Cr) have been synthesized and characterized structurally and magnetically. The Cu(II) ions adopt an axially-elongated octahedron with four N atoms from the Ln ligands occupying the equatorial plane and another two atoms (cyano nitrogen atoms or amide oxygen atoms) from two [M(bpb)(CN)2]− moieties at the axial positions, resulting in a neutral linear trinuclear complex. Magnetic studies show that the CuFe2 compound bridged by the amido group exhibits ferromagnetic behaviour. The two cyano-bridged CuFe2 or CuCr2 compounds show unusual magnetic properties: weak antiferromagnetic Cu(II)–Fe(III) coupling and negligible Cu(II)–Cr(III) magnetic exchange, proved by the results of the field dependence of magnetization.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: